Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03935399 · ClinicalTrials.gov registry record · Phase 4
Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin
A Phase 4 study of Chronic Pain, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03935399 is a Phase 4 study of Chronic Pain that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03935399, a Phase 4 study of Chronic Pain, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to evaluate the effects that a dose of oxytocin given by intramuscular (IM) injection (into the muscle) will have on an area of skin that has been exposed to ultraviolet (UV) light. The area of skin exposed to UV light will have a mild sun burn feeling. Sensory testing will be performed on the area of UV burn. The area will be evaluated for sensitivity in 3 methods: touch, vibratory
Conditions Studied
Interventions
- DRUG Saline
- DRUG Oxytocin
Study Locations (1)
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-08-08 |
| Est. Completion | 2020-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03935399
The ClinicalTrials.gov registry entry for NCT03935399 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (99% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT03935399 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03935399 about?
NCT03935399 is a clinical study titled "Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin". This study proposes to evaluate the effects that a dose of oxytocin given by intramuscular (IM) injection (into the muscle) will have on an area of skin that has been exposed to ultraviolet (UV) light. The area of skin exposed to UV light will have a mild sun burn feeling. Sensory testing will be p...
What is the current status of trial NCT03935399?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2019-08-08. Estimated completion is 2020-04-30.
What conditions does trial NCT03935399 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT03935399?
The interventions under investigation include: Saline (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03935399?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03935399 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow
RECRUITING · Phase 4
-
Stanford Pragmatic Effectiveness Comparison
RECRUITING · Phase 4
-
Better Options for Chronic Cancer Pain
RECRUITING · Phase 4
-
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
RECRUITING · Phase 4
-
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
ACTIVE NOT RECRUITING · Phase 4
-
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.